Bilingual women's health education your patients will actually use.
Amaranta gives your patients physician-reviewed answers in English and Spanish, on their own phone, from a QR code. They understand the evidence, recognize the warning signs, and arrive at the next visit with better questions.
The visit is short. The questions keep coming.
Patients search online between visits and find answers that are wrong, frightening or only in English. Clinics are asked to provide information in every patient's language, and to improve outcomes like postpartum depression follow-up, with less time per patient.
Language access, verified
Every topic is written in English and Spanish and reviewed by physicians. An automated check compares each Spanish version with the approved English for numbers, warning signs and instructions, so nothing is lost in translation.
Answers, not handouts
Short cards in plain language, plus a chat that answers follow-up questions from the same reviewed library and shows the source every time. When there is no reviewed answer, it says so.
Better-prepared patients
Every answer ends with questions to bring to the clinician. Warning signs that need care today are named plainly, with what to say when they call.
How it works in your clinic
Designed to take less than 15 seconds of clinician time.
Pick your conditions
Choose the topics your patients ask about most: pregnancy, postpartum, contraception, perimenopause, menopause and more. Your clinic name appears on the cards.
Share with a QR code
A one-page QR menu in the exam room, a QR on the after-visit summary, or a link by text. No patient information goes into the code.
Patients keep it on their phone
The cards are saved in a "From my doctor" section of the patient's own Amaranta, in her language, with no account. Each month you see an anonymous report of what patients opened and asked.
What the pilot showed
A two-week private pilot with 15 women in Tulsa, September–October 2026.
of questions were asked in Spanish
answer ratings were "helpful"
reports of a wrong or unsafe answer, across 84 answers
Who it's for
Educational, never diagnostic
Amaranta explains the evidence and names warning signs. It does not diagnose, score risk or recommend treatment, and it always sends patients back to their clinician.
Private by design
No patient accounts, no patient health information, no ads, no data sales. Clinic reports show anonymous counts and topics only.
Questions clinics ask
What is Amaranta for Clinics?
A bilingual (English and Spanish) women's health education library that clinics share with patients by QR code or link. Patients open short, plain-language cards on their phone, can ask follow-up questions, and every answer shows its source. All content is reviewed by physicians.
Do patients need an account or an app?
No. Patients scan a QR code or open a link. There is no account, and the cards are saved on the patient's own phone.
Does Amaranta collect patient health information?
No. The QR code identifies the clinic and the set of cards, never the patient. Clinic reports show anonymous counts and topics only.
Is Amaranta a medical device or a diagnostic tool?
No. Amaranta is educational. It does not diagnose, score risk or recommend treatment; it explains the evidence, names warning signs that need care, and helps patients prepare questions for their clinician.
How does it help with language access?
Every topic is written and physician-reviewed in both English and Spanish, and the Spanish is checked against the approved English for the same clinical facts, so Spanish-speaking patients get the same information.
How much does it cost?
The first clinic pilot is free for 60 days. After that, clinics and health plans pay an annual license quoted by size. Amaranta is always free for women.
Start a free 60-day pilot
Tell us about your clinic or organization and we'll reply within two business days. Every topic is physician-verified before a clinic pilot begins.
Prefer email? hello@docta.health
Looking for Amaranta for yourself? Join the waitlist: it opens to everyone in November 2026.